Minerva Surgical, Inc.
UTRS · OTC
12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | -3.5% | 38% | 45.2% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 54.2% | 58.6% | 50.6% | 45.4% |
| EBITDA | -$0 | $0 | $0 | -$0 |
| % Margin | -39.9% | 1.7% | 2.2% | -67.9% |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -67.8% | -41.2% | -48.4% | -200.1% |
| EPS Diluted | -23.68 | -14.98 | -17.91 | -75.29 |
| % Growth | -58.1% | 16.4% | 76.2% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | -$0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |